UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.11 +0.11 (+0.14%) GOLD FUTURES
2,311.70 +0.70 (+0.03%) DOW
38,159.28 +255.99 (+0.68%) Bitcoin GBP
47,139.38 +1,472.38 (+3.22%)
Ocugen, Inc. (OCGN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:47PM EDT. Market open.
| Previous close | 1.3900 |
| Open | 1.4057 |
| Bid | 1.3400 x 300 |
| Ask | 1.3900 x 700 |
| Day's range | 1.3200 - 1.4100 |
| 52-week range | 0.3450 - 2.1050 |
| Volume | |
| Avg. volume | 9,819,150 |
| Market cap | 344.815M |
| Beta (5Y monthly) | 3.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?
Ocugen (OCGN) is expected to provide updates regarding the developmental program of its lead candidate, OCU400, for two rare retinal diseases in the first-quarter earnings release.
- Zacks
Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study
Ocugen (OCGN) stock gains as the DSMB for the phase I/II study of OCU410 approves the initiation of dosing with the medium dose of OCU410 in the dose-escalation phase of the GA study.
© 2024 Yahoo. All rights reserved.